Company intelligence / Profile preview

Semex

Guelph, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Semex commercializes advanced genetic solutions including Immunity+ for disease resistance, and offers commercial reproductive technology services aimed at improving fertility, health, and profitability in cattle herds worldwide. Their solutions are widely adopted in dairy and beef production and are supported by proprietary genetic and embryology platforms.

Therapeutic areas: Women's HealthInfectious DiseasesOther
Modalities: Genetic selectionEmbryo technologyArtificial inseminationIn vitro fertilization
Industry: Veterinary

Beyond the preview

Go deeper on Semex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semex.

Explore the full profile